Applied Therapeutics is under fire as investors file a class action lawsuit following the FDA’s refusal to approve its lead drug, causing stock prices to plummet over 80%. Investors have until February 18, 2025, to join the lawsuit alleging securities fraud.

Investors have filed a class action lawsuit against Rentokil Initial plc, alleging securities fraud related to the company’s integration of Terminix. The lawsuit claims that Rentokil concealed significant challenges, negatively impacting investors.

Kyverna Therapeutics faces a class action lawsuit alleging the company made false statements and concealed critical information during its February 2024 IPO. Investors who purchased stock may be eligible to join the lawsuit led by Levi & Korsinsky, LLP.

Warner Bros. Discovery is confronting a class action lawsuit alleging that the company misled investors through false statements about its financial prospects during critical NBA negotiations.

Investors in MGP Ingredients, Inc. are being notified of a class action lawsuit alleging the company misled shareholders about demand and inventory levels in its brown goods segment. The lawsuit, led by Levi & Korsinsky, LLP, seeks to recover losses for investors affected between May 4, 2023, and October 30, 2024. The deadline to seek lead plaintiff status is February 14, 2025.

Investors have filed a class action lawsuit against Wolfspeed, Inc. after the company’s stock dropped by over 39% in a single day. The lawsuit alleges that Wolfspeed misled shareholders with revenue projections tied to its Mohawk Valley fabrication facility.

Investors have filed a class-action lawsuit against ASP Isotopes Inc., alleging the company misled shareholders by overstating its technology’s effectiveness and business prospects. Affected investors have until February 3, 2025, to join the lawsuit with no cost or obligation to participate.

Zeta Global Holdings Corp. is facing a class action lawsuit filed by Levi & Korsinsky, LLP, accusing the company of securities fraud that allegedly misled investors and artificially inflated financial results. Affected investors have until January 21, 2025, to join the lawsuit.

Investors in Humacyte, Inc. have filed a class action lawsuit alleging securities fraud against the company. The suit claims that Humacyte concealed critical manufacturing deficiencies, leading to investor losses. Affected shareholders have until January 17, 2025, to seek lead plaintiff status.

Investors in Joint Stock Company Kaspi.kz have until February 18, 2025, to join a class action lawsuit alleging securities fraud and undisclosed risks. The lawsuit, led by Levi & Korsinsky, LLP, accuses the company of misleading shareholders about business dealings and executive connections.

Investors in Celsius Holdings, Inc. have been notified of a class action lawsuit alleging securities fraud committed between February 2024 and September 2024. Levi & Korsinsky, LLP urges affected shareholders to act before the January 21, 2025, deadline to seek potential recovery of losses.

Investors in Aehr Test Systems are being notified of a class action lawsuit alleging securities fraud related to undisclosed order delays and overstated financial prospects. The lawsuit covers investors affected between January 9, 2024, and March 24, 2024, with a lead plaintiff deadline of February 3, 2025.

Levi & Korsinsky, LLP has filed a class action lawsuit against Customers Bancorp, Inc., alleging that the company misled investors about its anti-money laundering practices. Affected investors have until January 31, 2025, to seek lead plaintiff status.

Levi & Korsinsky, LLP has filed a class action lawsuit against ASML Holding N.V., alleging that the company misled investors about severe industry challenges and overstated growth prospects. Investors affected between January 24, 2024, and October 15, 2024, have until January 13, 2025, to seek lead plaintiff status.

Levi & Korsinsky has initiated a class action lawsuit against Capri Holdings Limited, alleging that the company engaged in securities fraud that led to significant investor losses.

Investors in Dentsply Sirona Inc. are being notified of a class action lawsuit alleging securities fraud related to the company’s Byte aligners. The lawsuit claims that Dentsply concealed severe patient injuries and failed to report them to the FDA, potentially misleading investors about the company’s financial health.

Five9, Inc. is facing a class action securities lawsuit alleging the company made false statements and concealed critical information affecting investors between June 4 and August 8, 2024. As the lead plaintiff deadline of February 3, 2025, approaches, investors are urged to consider their legal options.

Nvidia has unveiled a colossal opportunity to expand its business in the coming years, signaling significant growth prospects for investors. The tech giant highlights a $1 trillion chance set to transform its future landscape.

Levi & Korsinsky, LLP has filed a class action lawsuit against Hasbro, Inc., alleging that the toy giant misled investors about inventory levels, leading to inflated stock prices. Investors affected between February 7, 2022, and October 25, 2023, have until January 13, 2025, to join the lawsuit.